TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
101 hedge funds and large institutions have $129M invested in Tvardi Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
+20
Holders Change %
+24.69%
% of All Funds
2.53%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
32
Increased
31
Reduced
23
Closed
12
Calls
$1.78M
Puts
$583K
Net Calls
+$1.19M
Net Calls Change
–
Top Buyers
Top Sellers
1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.43M |
2 |
Renaissance Technologies
New York
|
-$2.07M |
3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.86M |
4 |
Allianz Asset Management
Munich,
Germany
|
-$1.09M |
5 |
Morgan Stanley
New York
|
-$934K |